Sort
78,016 grants matching “breast cancer”
Novel MUC1 Theranostic Peptides for Imaging and Treatment of Triple-Negative Breast Cancer
$475,676Corinne Beinat · Stanford University · R37 · FY2025 · CA
MIcroRNA: A Novel Genetic Modifier for Breast Cancer Predisposition
$475,640Hua Zhao · University Of Tx Md Anderson Can Ctr · R01 · FY2012 · CA
Combined Methylation and Mutation to Predict Response to PARP Inhibitors
$475,615Elizabeth Mary Swisher · University Of Washington · R01 · FY2024 · CA
Investigating the roles of extracellular cGAMP and harnessing it for cancer treatment
$475,613Aaron F Straight · Stanford University · R01 · FY2024 · CA
Molecularly-Targeted Ultrasound in Ovarian Cancer
$475,610Amelie Lutz · Stanford University · R01 · FY2020 · CA
Center of Excellence in Biobehavioral Approaches to Symptom Management
$475,609Rita H. Pickler · Virginia Commonwealth University · P30 · FY2009 · NR
Novel Protein Engineered Drug Conjugates Targeting Phosphatidylserine for the Treatment of Breast Cancer
$475,608Kevin G Pinney · Baylor University · R01 · FY2021 · CA
NEW YORK UNIVERSITY WOMENS HEALTH STUDY
$475,598New York University School Of Medicine · R01 · FY2000 · CA
Race,Treatment and Endometrial Cancer Survival
$475,581University Of Pennsylvania · R01 · FY2004 · CA
Describing and Understanding Racial Disparities
$475,578Jeffrey H Silber · Children'S Hosp Of Philadelphia · R01 · FY2010 · HS
Polygenic Risk Scores for Healthier African American Families
$475,567Cynthia A. Prows · Cincinnati Childrens Hosp Med Ctr · U01 · FY2023 · HG
Cancer Vaccines and Modulation of Checkpoint Controls in Immunization
$475,552John Janik · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Intraoperative Polarization-Sensitive OCT for Assessing Breast Tumor Margins
$475,541Stephen A Boppart · University Of Illinois At Urbana-Champaign · R01 · FY2018 · CA
NIH-NSF BBSI HST-MGH Summer Institute for Biomedical Optics
$475,439Martha L Gray · Massachusetts Institute Of Technology · · FY2002 · ENG
Breast Cancer Genomics in Windows of Susceptibility to Endocrine Disruptors
$475,396Susan L Teitelbaum · Icahn School Of Medicine At Mount Sinai · U01 · FY2014 · ES
Impact of cancer predisposition on oncogenic process, microenvironment, and treatment
$475,364Li Ding · Washington University · R01 · FY2025 · CA
Integrin Regulation of Cancer Progression Through Alternative mRNA Splicing and Nonsense-Medidated Decay (NMD)
$475,353C Michael Dipersio · Albany Medical College · R01 · FY2020 · CA
Targeting Acetyl-CoA Metabolism for the Discovery of New Anti-Cancer Therapeutics
$475,351Steven L McKnight · Ut Southwestern Medical Center · R01 · FY2016 · CA
Targeting Acetyl-CoA Metabolism for the Discovery of New Anti-Cancer Therapeutics
$475,351Steven L McKnight · Ut Southwestern Medical Center · R01 · FY2014 · CA
Targeting Acetyl-CoA Metabolism for the Discovery of New Anti-Cancer Therapeutics
$475,351Steven L McKnight · Ut Southwestern Medical Center · R01 · FY2015 · CA
Targeting Acetyl-CoA Metabolism for the Discovery of New Anti-Cancer Therapeutics
$475,351Steven L McKnight · Ut Southwestern Medical Center · R01 · FY2017 · CA
Targeting Notch, PI3K-AKT and other novel pathways in breast cancer stem cells
$475,325Jenny C-N Chang · Baylor College Of Medicine · R01 · FY2008 · CA
Promoting Effective Clinical Communication about Sexual Health after Gynecologic Cancer: A Randomized Controlled Trial of a Patient-Focused Intervention
$475,317Jennifer Barsky Reese · Research Inst Of Fox Chase Can Ctr · R01 · FY2024 · CA
Novel immune suppressive activities of Fas/CD95 in triple negative breast cancer
$475,275Marcus E Peter · Northwestern University At Chicago · R01 · FY2022 · CA
Defining and characterizing microenvironmental drivers of disseminated tumor cell dormancy in brain
$475,250Cyrus M Ghajar · Fred Hutchinson Cancer Center · R01 · FY2023 · CA